| Literature DB >> 35225987 |
Amir Taldaev1,2, Vladimir Rudnev1,3, Liudmila Kulikova4, Kirill Nikolsky1, Alexander Efimov5, Kristina Malsagova1, Anna Kaysheva1.
Abstract
Biological activity regulation by protein post-translational modification (PTM) is critical for cell function, development, differentiation, and survival. Dysregulation of PTM proteins is present in various pathological conditions, including rheumatoid arthritis (RA). RA is a systemic autoimmune disease that primarily affects joints, and there are three main types of protein PTMs associated with the development of this disease, namely, glycosylation, citrullination, and carbamylation. Glycosylation is important for the processing and presentation of antigen fragments on the cell surface and can modulate immunoglobulin activity. The citrullination of autoantigens is closely associated with RA, as evidenced by the presence of antibodies specific to citrullinated proteins in the serum of patients. Carbamylation and dysregulation have recently been associated with RA development in humans.In this study, we performed an overview analysis of proteins with post-translational modifications associated with the development of RA adverted in peer-reviewed scientific papers for the past 20 years. As a result of the search, a list of target proteins and corresponding amino acid sequences with PTM in RA was formed. Structural characteristics of the listed modified proteins were extracted from the Protein Data Bank. Then, molecular dynamics experiments of intact protein structures and corresponding structures with PTMs were performed regarding structures in the list announced in the ProtDB service. This study aimed to conduct a molecular dynamics study of intact proteins and proteins, including post-translational modification and protein citrullination, likely associated with RA development. We observed another exhibition of the fundamental physics concept, symmetry, at the submolecular level, unveiled as the autonomous repetitions of outside the protein structural motif performance globule corresponding to those in the whole protein molecule.Entities:
Keywords: citrullination; molecular dynamics; post-translational modification; rheumatoid arthritis; supersecondary structures
Year: 2022 PMID: 35225987 PMCID: PMC8884019 DOI: 10.3390/proteomes10010008
Source DB: PubMed Journal: Proteomes ISSN: 2227-7382
Data on intact three-dimensional structures of proteins, the modification of which is associated with RA.
| No. | UniProt ID * | Protein Name | Biological Process ** | PDB ID 3 * | Sequence with PTM Moiety | Mw, kDa | Number of a. a. | Aliphatic Index | Instability Index | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | P06733-2 | α-enolase | An enzyme of glycolysis, growth control, hypoxia tolerance, and allergic responses | 7 | 266-DPS R/Cit YISPDQLADLYKSFIK-285 | 47.2 | 434 | 88.6 | 36.5 | [ |
| 2 | P08670 | Vimentin | Class-III intermediate filaments | 2 | 136-EQLKGQGKS R/Cit LGDLYEEEMR-155 | 53.6 | 466 | 81.6 | 58.1 | [ |
| 3 | 1 | 371-NMKEEMARHL R/Cit EYQDLLNVK-390 | [ | |||||||
| 4 | 1 | 371-NMKEEMA R/Cit HLREYQDLLNVK-390 | [ | |||||||
| 5 | Q9UM07 | protein-arginine deiminase type-4 | Citrullination/deimination of arginine residues of proteins such as histones | 18 | 204-A R/Cit SEMDKV R/Cit VFQAT R/Cit GK-220 | 74.1 | 663 | 82.3 | 39.2 | [ |
| 6 | 18 | 375-GLKEFPIK R/Cit VMGPDFGYVTR-394 | [ | |||||||
| 7 | 18 | 480-PAPDRKGFRLLLASP R/Cit SCYK-499 | [ | |||||||
| 8 | P02778-2 | C-X-C chemokine 10 | Pro-inflammatory cytokine that is involved in apoptosis, chemotaxis, differentiation, regulation of cell growth | 4 | 24-LS R/Cit TVRCTCISISNQPVNPR-43 | 10.1 | 98 | 103.5 | 55.3 | [ |
| 9 | P02671 | Fibrinogen α-chain | Hemostasis | 2 | 29-AEGGGV R/Cit GPRVVE R/Cit HQSACK-48 | 98 | 866 | 53.1 | 40.8 | [ |
| 10 | 2 | 562-SHHPGIAEFPS R/Cit GKSSSYSK-581 | [ | |||||||
| 11 | 2 | 583-FTSSTSYN R/Cit GDSTFESKSYK-602 | [ | |||||||
| 12 | P02675 | Fibrinogen β-chain | Hemostasis | 28 | 266-Y R/Cit VYCDMNTENGGWTVIQNR-285 | 55.9 | 491 | 62.5 | 42.5 | [ |
| 13 | 28 | 254-MYLIQPDSSVKPY R/Cit VYCDMR-273 | [ | |||||||
| 14 | 4 | 55-EAPSL R/Cit PAPPPISGGGYRAR-74 | [ | |||||||
| 15 | P60709 | Actin, cytoplasmic 1 | Production of filaments that form cross-linked networks in the cytoplasm of cells | 7 | 88-HTFYNEL R/Cit VAPEEHPVLLTEAPLNPK-113 | 41.7 | 375 | 82 | 35.3 | [ |
| 16 | P01009 | α-1-antitrypsin | Inhibitor of serine proteases | 24 | 218-WE R/Cit PFEVKDTEEEDFHVDQVTTVK-241 | 46.7 | 418 | 91.2 | 31.6 | [ |
| 17 | P02647 | Apolipoprotein A-I | Reverse transport of cholesterol from tissues to the liver | 17 | 231-AKPALEDL R/Cit QGLLPVLESFK-250 | 30.8 | 267 | 84.8 | 40.8 | [ |
| 18 | P02656 | Apolipoprotein C-III | Triglyceride homeostasis | 1 | 47-LSSVQESQVAQQA R/Cit GWVTDGFSSLK-71 | 10.9 | 99 | 84.6 | 29.2 | [ |
| 19 | P02649 | Apolipoprotein E | Core component of plasma lipoproteins | 7 | 186-EGAE R/Cit GLSAIR-198 | 10.9 | 99 | 84.5 | 29.2 | [ |
| 20 | P02760 | Protein AMBP | Inhibition of trypsin, plasmin, and lysosomal granulocytic elastase | 2 | 294-GPC R/Cit AFIQLWAFDAVK-309 | 39 | 352 | 70.6 | 49.1 | [ |
| 21 | P00734 | Prothrombin | Blood homeostasis, inflammation and wound healing | 27 | 453-YNW R/Cit ENLD Cit DIALMK-467 | 70 | 622 | 69.8 | 40.9 | [ |
| 22 | 27 | 434-YE R/Cit NIEK-440 | [ | |||||||
| 23 | P02768 | Serum albumin | Regulation of the colloidal osmotic pressure of blood | 125 | 97-LCTVATL R/Cit ETYGEMADCCAK-117 | 69.4 | 609 | 77.6 | 39.1 | [ |
UniProt ID *—a knowledge base of protein amino acids sequences, PTM processing, and molecular functions. (Follow the link for more information: https://www.uniprot.org/) (accessed on 17 September 2021); **—from UniProt KB; PDB ID 3 *—the number of annotated in PDB structures available for the protein/peptide if interested.
Results of the MD experiment with the structural blocks of target proteins, the modification of which is associated with RA development.
| Parameter | Cut-Offvalue, nm | SASA of Arg (Lys)/Cit, nm2 | SASA of PTM Site, nm2 | Major Conformationlifetime (%) | Secondarystructureassignment (STRIDE) | Distance between COM of Ist and Last Element, nm | Pairwise RMSD | Pairwise RMSD MD of (PDB vs. PDB-PTM-MD), nm |
|---|---|---|---|---|---|---|---|---|
| Protein AMBP (PDB ID 1BIK) | ||||||||
| PDB | – | 3.623 | 10.505 | – | CCCCCCCCCCCEEEEEEETTTTEEEEEEEC | 0.197 | 0.152 | 0.352 |
| PDB-MD | 0.27 | 3.647± | 10.358± | 68 | CCCCCCC | 0.326± | ||
| PDB-PTM-MD | 3.531± | 10.538± | 41 | C | 0.289± | |||
| Albumin(PDB ID 1N5U) | ||||||||
| PDB | – | 3.741 | 10.669 | – | CCCHHHHHHHHHHHCCHHHHHHGGGGGGGGCCHHHHHHHHHHCC | 1.029 | 0.403 | 0.221 |
| PDB-MD | 0.25 | 3.639± | 10.348± | 85 | CCCHHHHHH | 0.969± | ||
| PDB-PTM-MD | 3.544± | 10.292± | 70 | CCCHHHHHH | 1.007± | |||
| Fibrinogen beta chain (PDB ID 3E1I) | ||||||||
| PDB | – | 3.611 | 12.713 | – | CEEEEETTTTTTCCEEEEEETTTTTTCEECCCCCC | 1.207 | 0.416 | 0.187 |
| PDB-MD | 0.3 | 3.645± | 13.426± | 74 | C | 0.932± | ||
| PDB-PTM-MD | 0.3 | 3.538± | 13.349± | 79 | CCEEEE | 0.882± | ||
| Actin, cytoplasmic 1 (PDB ID 6ANU) | ||||||||
| PDB | – | 3.472 | 10.080 | – | CCHHHHHHHHHHHHHHHCCCCGGGCCTTTCCTTTTCHHHHHHHHHHHHHHC | 1.344 | 0.257 | 0.223 |
| PDB-MD | 0.27 | 3.645± | 11.014± | 68 | CCHHHHHHHHHHHH | 1.061± | ||
| PDB-PTM-MD | 0.27 | 3.563± | 11.065± | 60 | CCHHHHHHHHHHHHHHHCCC | 1.202± | ||
| Tubulin polymerization-promoting protein (AF-H9GXR8-F1) | ||||||||
| PDB | – | 3.272 | 10.347 | – | CHHHHHHHHHHHTTTTTTTTTHHHHHHHHHHHCTTTTCCCCHHHHHHHHHHHHHHHC | 1.300 | 0.294 | 0.104 |
| PDB-MD | 0.23 | 3.255± | 10.937± | 70 | C | 1.214± | ||
| PDB-PTM-MD | 0.23 | 3.546± | 11.028± | 80 | C | 1.221± | ||
Figure 1RMSD plots of simulated protein during MD simulations. (a,b) show the RMSD of intact and citrullinated proteins, respectively. AMBP—protein AMBP, Alb—albumin, Fibr—fibrinogen, Act—actin, cytoplasmic 1; TubPPP—tubulin polymerization-promoting protein.
Figure 2Structural motifs containing PTM: (a) β-hairpin in protein AMBP (PDB ID 1BIK); (b) left-handed superhelix in albumin (PDB ID 1N5U); (c) 3ß-corner in fibrinogen (PDB ID 3E1I); (d) α-α-corner in actin, cytoplasmic 1 (PDB ID 6ANU); (e) Right-handed superhelix in tubulin polymerization-promoting protein (AF-H9GXR8-F1). Gray color indicates experimental or AF, green color indicates major conformation of the intact motif during the MD experiment, and blue color indicates the major conformation of the motif with PTM during the MD experiment. Citrullines are designated by sticks.